Additional file 1: of Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results

Abstract

Trastuzumab Duration questionnaire. The questionnaire that was completed by the oncologists. (PDF 476 kb